StockData

Axogen vs Establishment Labs

AXGN and ESTA side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How AXGN and ESTA compare

Axogen is the larger company, worth 1.6 times as much as Establishment Labs ($3.3B against $2.1B).

Establishment Labs grew revenue faster over the last twelve months (38.3% versus 24.3% for Axogen).

Axogen keeps more of each dollar of sales as profit, with a net margin of −12.0% compared with −14.6% at Establishment Labs.

Axogen scores higher on the StockData Score (11 against 6 for Establishment Labs), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricAXGNESTA
Size and price
Market cap$3.3B$2.1B
Share price$55.37$69.51
Change, 1 year135%8.6%
Change, 5 years477%4.7%
Beta (5Y)1.320.67
Employees6221,004
StockData Score
Total score11 (better)6
Valuation score00
Growth score33
Performance score3 (better)2
Health score5 (better)1
Dividend score00
Valuation
P/S12.4×7.8× (better)
P/B6.7× (better)133×
P/FCF150×–
FCF yield0.67% (better)−1.0%
Fair value$22.90–
Margin of safety−142%–
Growth
Revenue growth (TTM)24.3%38.3% (better)
Revenue growth, 5Y average14.9%20.0% (better)
Profitability
Gross margin74.2% (better)70.2%
Operating margin−5.2% (better)−6.6%
Net margin−12.0% (better)−14.6%
FCF margin8.3% (better)−8.2%
Return on equity−10.3% (better)−241%
Return on invested capital−7.9%−6.7% (better)
Financial health
Debt / equity0.0017.17 (better)
Interest coverage−5.7×−0.6× (better)
Current ratio12.02 (better)3.57
Altman Z-score37.04 (better)2.74
Piotroski F-score5 (better)3
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions90.4%95.8%
Held by insiders7.6%9.6%
Insider net buying, 12 months−$17.1M (better)−$35.5M
Short interest, % of float12.7%14.6%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.